Inhibitor drug entinostat ‘primes’ the body to better respond to anti-cancer treatment with immunotherapy
Combining a histone deacetylase inhibitor drug with immunotherapy agents has been deemed safe, and may benefit some patients with advanced cancers that have not responded to traditional therapy, ac…
